TRMT2A and neoplasm: Given TRMT2A's strong prognostic association in HER2 expressing patients and its periodic expression during the cell cycle, it is interesting to speculate that TRMT2A over-expression may reflect tumor cells driven by an activated HER2 pathway towards aggressive growth.